Decentralized protocol Injective has announced the launch of its inEVM layer 2 accumulative solution on the mainnet.
According to a post from the Injective team on Mar. 7, Injective is launching inEVM on the mainnet, the first Ethereum Virtual Machine capable of achieving true composability across Injective and Ethereum.
1/ Injective #inEVM is live on mainnet, the first ever rollup designed to supercharge concurrent VM development.
inEVM enables Ethereum developers to build dApps that leverage blazing fast speeds & near zero fees while achieving composability across WASM and EVM
Read on 👇 pic.twitter.com/OXtPQTVnvx
— Injective 🥷 (@injective) March 7, 2024
“Injective’s inEVM enables Ethereum developers to build applications that can uniquely leverage Injective’s blazing fast speeds and near zero fees while simultaneously achieving composability across the WASM and EVM world.”
Injective team
Last September, Injective released the inEVM testnet in partnership with Caldera. InEVM from Injective allows Ethereum developers to deploy their applications on Injective without changing code.
According to the developers, this allows Injective to be the only layer 1 blockchain capable of combining Cosmos compatibility with the speed of Solana and developer access of Ethereum.
You might also like: Flipside sees rising EVM adoption in 2024 for cost-effective Ethereum alternatives
Amid the launch of the mainnet, INJ jumped 14%. At the time of writing, the token is trading at $43.40, increasing its market capitalization to $4 billion on the back of the latest initiative.
Source: CoinMarketCap
In January, Injective also announced the imminent staking of 50% of the total INJ token supply. Experts consider this an essential step in decentralizing the network. The news followed shortly after Injective released a major mainnet update called Volan.
You might also like: Exploring the expansive ecosystem of EVM-compatible chains
